Bone Tumor Surgery

Introduction

If you or someone in your family has been told there is a tumour in a bone, the days that follow are usually filled with scans, biopsies, and conversations about what comes next. Some bone tumours are benign (non-cancerous) and can be managed with a relatively simple operation. Others are malignant (cancerous) and need a carefully planned combination of surgery, chemotherapy, and sometimes radiation. In almost all cases — benign or malignant — surgery plays a central role in treatment.

This guide is written for patients and families who already have a diagnosis or are in the middle of staging and treatment planning. It explains what bone tumour surgery is, when it is used, the main surgical approaches (including limb-salvage and amputation), how reconstruction works, what recovery looks like, the risks involved, and how follow-up is organised. It also includes a dedicated section on children and adolescents, because the most common primary bone cancers occur in younger patients and the surgical considerations are different.

The information here is general. Every bone tumour is unique in its type, size, location, and behaviour, and the right surgical plan for you can only be decided together with an orthopaedic oncology team and a multidisciplinary tumour board.

What Is Bone Tumour Surgery?

Bone tumour surgery — sometimes called orthopaedic oncology surgery — is the surgical removal of an abnormal growth in or on a bone. The aims of surgery depend on whether the tumour is benign or malignant, but the broad goals are similar: remove the abnormal tissue completely, stabilise the bone, relieve pain, restore as much function as possible, and, in the case of cancer, reduce the chance of recurrence.

• Benign bone tumours — non-cancerous growths such as osteochondroma, enchondroma, giant cell tumour of bone, aneurysmal bone cyst, and osteoid osteoma. Many never need surgery; others do, particularly if they cause pain, weaken the bone, or behave aggressively.
• Primary malignant bone tumours — cancers that start in the bone itself. The most common are osteosarcoma, Ewing sarcoma, and chondrosarcoma. These are rare overall but are an important cause of cancer in children, teenagers, and young adults.
• Metastatic bone tumours — cancer that has spread to bone from another organ, most commonly breast, prostate, lung, kidney, or thyroid cancer. Surgery here is usually about stabilising the bone and controlling pain rather than cure.

The surgical approach is different for each category, and within each category it is shaped by the exact diagnosis, the location of the tumour, and how far it has spread. A small benign cyst in the upper arm and an osteosarcoma around the knee require very different operations, even though both fall under the umbrella of bone tumour surgery.

One concept that comes up repeatedly in these discussions is the surgical margin — how much normal tissue is removed around the tumour. The Musculoskeletal Tumor Society describes margins as intralesional (cutting through the tumour, as in curettage), marginal (along the edge of the tumour), wide (a cuff of healthy tissue around the tumour), and radical (removing the entire bone compartment). For most malignant bone tumours, a wide margin is the goal because it gives the lowest risk of local recurrence.

Why Bone Tumour Surgery Is Performed

Surgery is recommended for a wide range of reasons. The specific indication shapes how aggressive the operation needs to be and what reconstruction, if any, is required.

Common reasons surgeons recommend bone tumour surgery include:

• Confirmed primary bone cancer — osteosarcoma, Ewing sarcoma, chondrosarcoma, and other sarcomas almost always require surgery as part of curative treatment, alongside chemotherapy or radiation where appropriate.
• Aggressive or symptomatic benign tumours — some benign tumours, such as giant cell tumour of bone or aneurysmal bone cyst, can destroy normal bone, cause severe pain, or recur if not treated. Surgery is often the most reliable way to control them.
• Risk of fracture — a tumour that has weakened a major bone (often called an impending pathological fracture) may need surgery to stabilise the bone before it breaks.
• Existing pathological fracture — if a bone has already broken through a tumour, surgery may be needed both to fix the fracture and to address the tumour.
• Pain or loss of function — tumours that affect joints or nearby nerves can cause persistent pain or limit movement. Surgery may relieve symptoms and improve quality of life, even in metastatic disease.
• Diagnostic uncertainty — in some cases, an open biopsy and definitive surgery may be combined when imaging strongly suggests a particular diagnosis.
• Metastatic disease causing structural problems — for cancer that has spread to bone, surgery can stabilise weight-bearing bones, fix fractures, or relieve spinal cord pressure.

Not every bone tumour needs surgery. Many benign tumours found by chance on imaging can be watched safely, and some metastatic lesions are managed with radiation, medication, or a combination of approaches. The decision to operate is taken case by case, usually after discussion in a multidisciplinary tumour board where surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists review the case together.

Who Is a Candidate?

Whether you or your child is a candidate for bone tumour surgery depends on several factors:

• The tumour itself — its type, size, exact location, behaviour, and whether it has spread.
• Anatomical involvement — whether the tumour has reached major blood vessels, nerves, joints, or skin. Heavy involvement of these structures changes what is surgically possible.
• Response to chemotherapy or radiation — for cancers such as osteosarcoma and Ewing sarcoma, chemotherapy usually comes first. How well the tumour shrinks and responds affects surgical planning.
• General health and fitness — major bone tumour surgery is long and physically demanding. Heart, lung, kidney, and nutritional status all influence whether and how surgery should proceed.
• Age and skeletal maturity — in children whose bones are still growing, the surgical plan has to account for future growth (covered in the children's section below).
• Patient priorities — the choice between limb-salvage and amputation, the type of reconstruction, and the expected functional outcome are all topics that need to be discussed openly with you. A team that listens to your goals as well as the medical facts is essential.

It is reasonable, and often encouraged, to seek a second opinion from another sarcoma centre before committing to a major operation. Bone sarcomas are rare and benefit from being treated in centres that see them regularly.

Alternatives and Complementary Treatments

Surgery is central to bone tumour treatment, but it is rarely the only treatment used, and in some situations other approaches may take its place.

Observation. Many benign bone tumours, especially those found incidentally on imaging done for other reasons, do not need treatment. Periodic imaging and clinical review may be all that is required. Examples include some non-ossifying fibromas, asymptomatic enchondromas, and stable osteochondromas in adults.

Chemotherapy. For osteosarcoma and Ewing sarcoma, chemotherapy is given both before surgery (neoadjuvant) and after surgery (adjuvant). This combination, refined over decades, has substantially changed the outlook for these cancers. Chemotherapy alone does not usually cure bone sarcomas, but without it, surgery alone is much less effective.

Radiation therapy. Radiation is the mainstay for some bone tumours and is used alongside surgery in others. Ewing sarcoma can be radiation-sensitive, and radiation may be used when complete surgical removal is not possible. For chordoma (a rare tumour of the spine and skull base) and some chondrosarcomas, advanced radiation techniques including proton therapy are used. For painful bone metastases, radiation often relieves pain quickly.

Targeted therapy and immunotherapy. For certain bone tumours and metastatic disease from particular cancers, targeted drugs may be part of the plan. Denosumab, for example, is used for giant cell tumour of bone and for bone metastases. Tyrosine kinase inhibitors play a role in selected sarcomas.

Image-guided minimally invasive techniques. For some benign tumours (such as osteoid osteoma) and some painful metastases, radiofrequency ablation, cryoablation, or cementoplasty performed by an interventional radiologist may avoid open surgery altogether.

Pain and supportive care. For people with advanced cancer for whom curative treatment is not realistic, the focus may shift to pain control, palliative radiation, bone-strengthening medications, and supportive care. This is not "no treatment" — it is treatment aimed at comfort and function.

Whether any of these alternatives is appropriate depends entirely on the diagnosis and stage. The aim of mentioning them here is not to suggest you should request a particular alternative but to show that the treatment landscape is wider than surgery alone, and that the right plan is the one shaped by your tumour board.

Surgical Approaches

The phrase "bone tumour surgery" covers several quite different operations. Which one is used depends on the tumour type, its location, and how much surrounding tissue must be removed for safety.

Curettage and Cavity Filling

For many benign and locally aggressive tumours, the surgeon scrapes the tumour out of the bone with a curette — a spoon-shaped instrument — through an opening made in the bone. The cavity left behind is often enlarged slightly to remove microscopic tumour cells (extended curettage) and may be treated with adjuvants such as a high-speed burr, phenol, or liquid nitrogen, depending on the surgeon's preference and the tumour type. The cavity is then filled with bone graft, bone substitute, or bone cement (polymethyl methacrylate) to restore strength. Metal implants may be added to support the bone while it heals.

Curettage is commonly used for tumours such as giant cell tumour of bone, aneurysmal bone cyst, chondroblastoma, and some enchondromas. It is less invasive than wide resection but carries a higher risk of local recurrence, which is why follow-up imaging is important.

Wide Resection (En Bloc Resection)

For most malignant bone tumours, the entire tumour is removed in one piece along with a cuff of healthy tissue around it. The resected specimen is sent to pathology, where margins are examined carefully to confirm that no tumour reaches the cut surface. Wide resection is the surgical foundation of curative treatment for osteosarcoma, Ewing sarcoma, chondrosarcoma, and many other primary bone cancers.

What is removed depends on the location: a segment of a long bone, an entire end of a bone with its joint, part of the pelvis, a rib, a vertebra, or a section of the shoulder blade. The defect left behind is then reconstructed.

Limb-Salvage Surgery

Limb-salvage surgery is the umbrella term for any operation that removes a bone tumour while preserving the limb. It combines wide resection with reconstruction of the gap. Improvements in imaging, surgical planning, and reconstruction techniques have made limb-salvage the standard of care in most centres for the majority of patients with extremity bone sarcomas, when it can be done safely.

Reconstruction options include:

• Endoprosthesis — a custom metal implant that replaces the removed bone and joint. Modular and custom-made endoprostheses are used around the knee, hip, shoulder, and elbow.
• Allograft — bone from a donor, used either alone or in combination with an implant (allograft-prosthetic composite).
• Autograft — bone taken from elsewhere in the patient's own body, such as the fibula, which can be transplanted with its blood supply (vascularised fibular graft).
• Combination reconstructions — mixing implants, allograft, autograft, and biological materials to match the defect.

Amputation

Amputation is removal of part of a limb. Although limb-salvage is now possible for most extremity bone tumours, amputation remains the right choice in certain situations:

• When major nerves and blood vessels are extensively involved by tumour and cannot be safely separated
• When the tumour is very large or has broken through skin
• When infection or complications make limb-salvage unsafe
• When a previous limb-salvage has failed
• When the expected functional outcome of limb-salvage would be worse than that of amputation with a modern prosthesis
• When the patient, after full discussion, prefers amputation

It is important to be clear that amputation is not a "failure" of treatment. For some patients, it offers faster recovery, fewer long-term complications, and excellent function with a well-fitted prosthesis. The decision between limb-salvage and amputation is one of the most personal conversations in bone tumour care and deserves time, honest information about expected outcomes, and access to a prosthetist and rehabilitation team early in the discussion.

Rotationplasty

Rotationplasty is a specialised operation used mostly in children and young adults with tumours around the knee. The segment of leg containing the tumour is removed; the lower leg is then rotated 180 degrees and reattached so that the ankle joint functions as a knee. With a below-knee prosthesis, the result is often a very durable and active limb. It can look unusual at first, but functional outcomes in active children and athletes are often excellent and very durable over decades.

Pelvic and Spinal Bone Tumour Surgery

Tumours of the pelvis (internal hemipelvectomy) and spine are among the most technically demanding bone tumour operations. They often involve close cooperation between orthopaedic oncology, neurosurgery, vascular surgery, plastic surgery, and urology. Reconstruction may involve custom 3D-printed implants, allografts, or, in some cases, leaving the gap unreconstructed with rehabilitation aimed at functional adaptation.

Surgery for Bone Metastases

Surgery for metastatic bone disease usually has different goals from surgery for primary bone cancer. The aim is generally to stabilise weight-bearing bones, prevent or fix fractures, relieve pain, and preserve mobility — rather than to cure. Common operations include intramedullary nailing (a metal rod inside the bone), plate and screw fixation, joint replacement for fractures near a joint, and decompression and stabilisation of the spine. Radiation often follows surgery to control microscopic disease.

Image-Guided and Minimally Invasive Procedures

For some benign tumours, such as osteoid osteoma, radiofrequency ablation through a small needle — performed under CT guidance — can destroy the tumour without open surgery. Cementoplasty (injection of bone cement) can strengthen painful metastatic lesions in the spine and pelvis. These techniques do not replace open surgery for most cancers but are useful options in selected cases.

Preparing for Bone Tumour Surgery

Preparation for bone tumour surgery is more involved than for many other operations because the planning has to account for both cancer control and reconstruction.

Staging investigations. Before surgery, your team will want a clear picture of the tumour and whether it has spread. Typical investigations include:

• MRI of the affected bone and surrounding soft tissues, to map the tumour precisely
• CT scan of the chest, because lungs are the most common site of spread for bone sarcomas
• Whole-body bone scan or PET-CT scan, depending on the diagnosis
• X-rays of the affected bone
• Blood tests including full blood count, kidney and liver function, and inflammatory markers

Biopsy. A tissue diagnosis from a biopsy is almost always needed before definitive surgery for a suspected sarcoma. The biopsy should ideally be planned by, or in close consultation with, the surgeon who will perform the definitive operation. A poorly placed biopsy track can contaminate tissues that would otherwise have been spared and can complicate later surgery. This is one of the strongest arguments for having care at a sarcoma centre from the start.

Tumour board review. Sarcoma centres routinely discuss new cases at a multidisciplinary tumour board. Your case will usually be reviewed and the surgical plan agreed before chemotherapy or surgery begins.

Neoadjuvant therapy. For osteosarcoma and Ewing sarcoma, chemotherapy is normally given before surgery. This serves two purposes: it shrinks the tumour, often making surgery easier and more limb-sparing, and it treats microscopic spread early. The response of the tumour to chemotherapy — measured on the surgical specimen — is an important prognostic marker.

Anaesthesia and fitness assessment. An anaesthesiologist will review your overall fitness, heart and lung function, and any medications. For long operations, blood may be cross-matched in advance.

Reconstruction planning. If an implant or allograft will be used, it may be designed or ordered ahead of time based on imaging. For complex pelvic and spinal cases, 3D-printed models or implants may be used.

Rehabilitation pre-planning. Meeting a physiotherapist before surgery is often helpful. For patients facing amputation, meeting a prosthetist and, where possible, other patients with similar surgery can make the transition easier.

Practical and emotional preparation. Bone tumour surgery is a major life event. Arranging support at home, time off work or school, and access to counselling or peer support before surgery is worthwhile. Many sarcoma centres include a psychologist or social worker in the team.

What Happens During Bone Tumour Surgery

The exact steps depend on the operation, but a typical major bone tumour operation follows this general flow:

• You are admitted to hospital, usually the day before or on the morning of surgery.
• You meet the surgical and anaesthesia teams. The site and side of surgery are confirmed and marked.
• General anaesthesia is given. Regional anaesthesia (such as a nerve block) may be added for pain control.
• You are positioned carefully, taking pressure off nerves and skin during a long operation.
• The surgical team makes the planned incision and exposes the tumour, protecting nerves, vessels, and surrounding healthy tissue.
• The tumour is removed — by curettage, wide resection, or amputation, depending on the plan.
• The specimen is sent to pathology. In some cases, frozen-section margins are checked during surgery.
• Reconstruction is performed if needed: implant, allograft, autograft, or a combination.
• Drains may be placed, and the wound is closed in layers.
• You are moved to the recovery area or intensive care for close monitoring.

Operations may take anywhere from one to two hours for a straightforward curettage to eight or more hours for complex pelvic or spinal resection with reconstruction. The team should be able to give you a realistic estimate ahead of time.

Recovery and Healing

Recovery from bone tumour surgery happens in phases. The pace depends on the size and location of the tumour, the type of reconstruction, and whether chemotherapy or radiation continues afterwards.

The Hospital Stay

After surgery you will usually wake up in a recovery area before moving to a ward or intensive care unit. Expect:

• Pain control through a combination of intravenous medicines, sometimes a patient-controlled analgesia pump, regional blocks, and later oral medicines
• Drains near the wound for one to several days
• Antibiotics to reduce infection risk
• Medication to reduce the risk of blood clots
• Early breathing and leg exercises to prevent chest and clot complications
• Gradual sitting up, standing, and supervised mobilisation as your team allows

Hospital stay typically ranges from a few days for simple curettage to two weeks or more for complex resection and reconstruction.

The First Weeks at Home

Once you are home, the focus is on wound healing, pain control, gradual mobilisation, and starting structured physiotherapy. Wound checks, suture or staple removal, and early follow-up imaging are usually arranged within the first few weeks. Weight-bearing on a reconstructed limb is often restricted at first; how soon you can put weight through it depends on the type of reconstruction and the surgeon's protocol.

Physiotherapy and Rehabilitation

Rehabilitation is the engine of functional recovery after bone tumour surgery. A typical programme includes:

• Range-of-motion exercises started early to prevent stiffness
• Strengthening of muscles around the operated area and elsewhere in the body
• Gait training with crutches, walker, or other aids
• Progressive weight-bearing as the bone, implant, or graft heals
• For amputation patients: stump care, prosthetic fitting, gait training with the prosthesis
• Functional retraining for daily activities, work, school, or sport

Rehabilitation often continues for months and sometimes years. Working with a physiotherapist who has experience in orthopaedic oncology rehabilitation can make a substantial difference.

Recovery Timeline

• Weeks 1–2: Wound healing, pain settling, gentle mobilisation
• Weeks 4–6: Suture and staple healing complete; progressive movement and supervised exercise
• 3 months: Improved strength and range of motion; many patients walking with or without aids
• 6 months: Substantial functional gains; return to many daily activities
• 12 months: Continued strengthening and adaptation; most of the functional recovery achieved

If chemotherapy continues after surgery, fatigue and immune suppression can make rehabilitation feel slower. This is expected, and progress usually picks up once treatment is complete.

Risks and Complications

All major surgery carries risks, and bone tumour surgery is no exception. Understanding these risks helps you prepare and recognise problems early.

General surgical risks include:

• Bleeding and the need for transfusion
• Reaction to anaesthesia
• Blood clots in the legs or lungs
• Chest infection
• Wound healing problems

Specific risks for bone tumour surgery include:

• Surgical site infection. Rates are higher than in routine orthopaedic surgery because of long operating times, large wounds, prior chemotherapy, and the use of large implants. Deep infection of an endoprosthesis can be very challenging to treat and sometimes requires further surgery.
• Nerve injury. Nerves close to the tumour may need to be carefully separated. Permanent or temporary weakness or numbness is possible.
• Vascular injury. Major blood vessels near the tumour may need to be reconstructed.
• Implant complications. Endoprostheses can loosen, wear, or break over years. Revision surgery may be needed at some point, particularly in younger patients whose implants must last decades.
• Allograft complications. Donor bone can fail to unite with the patient's bone, fracture, or become infected.
• Limb length difference. In children, removing a section of growing bone can lead to limb length differences over time. Expandable prostheses and limb-lengthening procedures may be used to manage this.
• Joint stiffness and reduced function. Even with excellent surgery and rehabilitation, the operated limb may not fully match the unaffected side.
• Local recurrence. The tumour can come back at the site of surgery, especially if margins were close or response to chemotherapy was poor.
• Distant recurrence. For malignant tumours, spread to lungs or other sites can occur even after successful local surgery.
• Phantom limb sensation and pain. After amputation, many patients experience phantom sensations, which usually settle but sometimes need specific treatment.

Experienced orthopaedic oncology teams reduce these risks through careful planning, meticulous technique, structured infection prevention, and dedicated rehabilitation pathways.

Adjuvant Treatment: Chemotherapy and Radiation

For most primary bone cancers, surgery alone is not enough. Chemotherapy, given before and after surgery, is the standard for osteosarcoma and Ewing sarcoma in NCCN and ESMO guidelines. Radiation therapy is often part of treatment for Ewing sarcoma when complete surgical margins are difficult to achieve, and is used for some chondrosarcomas, chordomas, and bone metastases.

Adjuvant treatment is planned in coordination with surgery. Chemotherapy may be paused around the operation to allow healing. Radiation, when used, is timed to balance tumour control with wound healing and reconstruction. These decisions are made by the tumour board so that surgery and systemic treatment work together rather than against each other.

Outcomes and Prognosis

Outcomes after bone tumour surgery vary widely depending on the diagnosis. A few general patterns are worth understanding:

• Benign bone tumours generally have an excellent outlook when completely removed. Some, such as giant cell tumour of bone, can recur locally and need careful follow-up.
• Localised osteosarcoma in children and young adults treated with combined chemotherapy and wide resection has substantially improved over recent decades. Long-term survival rates published in international cooperative trials are generally in the range of two-thirds to three-quarters of patients, though the figure for any individual depends on tumour location, response to chemotherapy, and other factors.
• Localised Ewing sarcoma treated with combined chemotherapy and local control (surgery, radiation, or both) also shows long-term survival in a similar range, again depending on individual factors.
• Chondrosarcoma outcomes depend heavily on grade. Low-grade chondrosarcomas have very high cure rates after adequate surgery, while high-grade and dedifferentiated tumours are more challenging.
• Metastatic disease at diagnosis generally has a more guarded outlook, though some patients with limited lung metastases can still achieve long-term remission with aggressive treatment.
• Surgery for bone metastases is usually about quality of life and function rather than cure; well-selected operations can dramatically reduce pain and restore mobility.

Published survival ranges should be treated as broad guides, not personal predictions. Your oncology team is the right source for a prognosis that takes account of your specific tumour type, stage, response to treatment, and overall health.

Life After Bone Tumour Surgery

Life after bone tumour surgery is shaped by what was removed and how it was reconstructed, by any continuing cancer treatment, and by the gradual work of rehabilitation.

Function. Many patients with limb-salvage reach a level of function that allows walking, work, study, and many leisure activities. High-impact sport may be limited around an endoprosthesis to protect the implant. Patients with amputation, with modern prostheses and dedicated rehabilitation, often regain a high degree of independence; some return to running, sport, and demanding work.

Surveillance follow-up. For malignant tumours, follow-up is structured and long-term. A typical schedule, broadly aligned with NCCN and ESMO bone sarcoma guidance, includes:

• Clinical review and imaging every 3 months for the first 2 years
• Every 6 months in years 3 to 5
• Annually thereafter, often continuing for at least 10 years

Imaging usually includes X-rays of the operated area, CT of the chest to check for lung metastases, and other studies as needed. Follow-up also screens for late effects of chemotherapy and radiation, such as heart, hearing, fertility, and secondary cancer risks.

Mental health. Anxiety, low mood, body-image concerns, and fear of recurrence are common after bone tumour treatment. These are not signs of weakness; they are part of recovery for many patients. Counselling, peer support groups, and specialist psycho-oncology services can help.

Return to work and study. Returning to work or school is often a major goal. Phased return, workplace adjustments, and continued physiotherapy can make this smoother. School-age children often need an individualised plan covering both physical access and the time missed during treatment.

Sexuality and relationships. Body changes from surgery, prosthesis use, and the effects of chemotherapy can affect intimate relationships. These topics are appropriate to raise with your team or with a specialist counsellor.

Bone Tumour Surgery in Children and Adolescents

Osteosarcoma and Ewing sarcoma occur most commonly in children, teenagers, and young adults, which means a significant proportion of bone tumour surgery is performed in this age group. Several considerations are different from adult surgery.

The growing skeleton. Removing part of a long bone in a child whose skeleton is still growing creates a future problem: limb length difference as the unaffected limb continues to grow. The team plans around this from the start. Options include:

• Expandable endoprostheses — implants that can be lengthened, either through small operations or, in some designs, non-invasively using a magnetic external device. Periodic lengthening keeps pace with growth on the other side.
• Rotationplasty — particularly useful for younger children with tumours around the knee, because the rotated ankle continues to grow and provides a durable, biological "knee" for many decades.
• Allograft and autograft reconstructions — biological reconstruction may be preferred in some growing patients.
• Limb-shortening or limb-lengthening procedures — staged operations elsewhere in the limb can adjust length over time.

Chemotherapy planning. Children receive multi-agent chemotherapy delivered to defined protocols in specialist paediatric oncology centres. Surgery is timed within the chemotherapy schedule to limit delays and protect healing.

Psychological and developmental needs. Treatment falls during important years of school, friendships, and identity formation. Paediatric and adolescent oncology teams include child life specialists, psychologists, teachers, and social workers, and family-centred care is the standard. Adolescents in particular benefit from being involved directly in decisions about their treatment, including the choice between limb-salvage and amputation or rotationplasty.

Long-term follow-up. Children who survive bone cancer need lifelong surveillance, both for tumour recurrence and for late effects of chemotherapy and radiation on heart, hearing, fertility, and secondary cancer risk. Many centres have dedicated long-term survivor clinics.

Frequently Asked Questions

How do I know whether I will need limb-salvage surgery or amputation?
This is decided by your orthopaedic oncology team based on the tumour's size, location, involvement of major nerves and blood vessels, your response to chemotherapy where relevant, and your own priorities. Many centres now achieve limb-salvage in the majority of extremity sarcomas, but amputation remains the right answer in some situations and gives excellent function for many patients.

Is bone tumour surgery always combined with chemotherapy?
No. Benign tumours generally do not need chemotherapy. For malignant tumours, chemotherapy is standard for osteosarcoma and Ewing sarcoma, often less central for chondrosarcoma, and varies for other sarcomas and metastatic disease. The tumour board decides based on the specific diagnosis.

How long will I be in hospital?
Anywhere from a few days for simpler curettage operations to two weeks or more for complex resection and reconstruction. Your team can give a more specific estimate once the operation is planned.

Will I be able to walk normally after surgery?
Many patients achieve a functional walking pattern, with or without aids. The exact level of function depends on which bones and joints were involved, the type of reconstruction, and rehabilitation. High-impact sport may be limited around large implants. After amputation, a well-fitted prosthesis and dedicated rehabilitation often allow walking, work, and many sports.

Can the tumour come back?
Local recurrence is possible, particularly when margins were close or response to chemotherapy was poor. Distant recurrence, especially in the lungs, is also possible for malignant bone tumours. This is why structured surveillance imaging continues for years after treatment.

Will the implant last my whole life?
Endoprostheses are durable but mechanical. Over decades, loosening, wear, or breakage can occur, particularly in active and younger patients. Revision surgery may be needed at some point. Newer implant designs and improved fixation have extended implant survival considerably.

How soon after surgery does chemotherapy or radiation start?
Usually within a few weeks, once wound healing is well established. Your medical oncologist and surgeon will coordinate the timing.

Can children return to school during or after treatment?
Yes. Many children return to school in some form during treatment, with adjustments for fatigue, immune suppression, and physical access. Schools and treating teams usually work together on an individualised plan.

How long does follow-up continue?
For malignant bone tumours, follow-up usually continues for at least 10 years, becoming less frequent over time. Long-term survivors of childhood bone cancer often remain in survivorship care indefinitely to monitor for late effects.

Should I get a second opinion?
Bone sarcomas are rare and benefit from being managed in centres that see them regularly. A second opinion at another sarcoma centre is reasonable and is often welcomed by the primary team, particularly before major surgery.

Conclusion

Bone tumour surgery covers a wide range of operations — from minor curettage of a small benign lesion to complex resection and reconstruction for cancer of the pelvis or spine. What unites them is the need for precise diagnosis, careful staging, multidisciplinary planning, and a team with deep experience in orthopaedic oncology. For most patients today, limb-salvage with reconstruction is possible, and for those who need amputation, modern prosthetics and rehabilitation often deliver excellent function.

The most important decisions in bone tumour treatment — whether surgery is needed, which approach to use, what reconstruction to choose, and how chemotherapy or radiation fits in — are made in conversation between you, your family, and a multidisciplinary tumour board. Understanding the broad shape of the journey, as set out in this guide, can help you take part in those conversations with greater clarity and confidence.